A visual depiction of HIV in the human body. Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Atomo Diagnostics (ASX:AT1) has confirmed it’s set to make $1.3M over the next 2 years by having its HIV self-test kits expanded to 70 sites around the country.

Delivered in vending machines, the company has the only self-test kit for HIV recognised by the domestic regulator’s approved devices list.

It had gazed into a crystal ball earlier this year to note the Federal budget had measures set aside for such a national rollout, given it was the only real operator in the space.

Currently, some 6 machines are located in South Australia but by 2025 that number will grow more than tenfold in every state and territory.

At the same time, a separate program in NSW is also set to incorporate some of the vended self-test kits.

Notably, the company was firm in its guidance for $1.3M in revenue.

“Based on funding recently committed by the Federal government … the company is budgeting, not forecasting, revenue from the program over the next two years of approximately $1.3 million,” Atomo wrote on Wednesday.

Management noted the growing trend of self-testing kits in HIV programs administered by world governments.

“Self-testing is now recognised by governments around the world as cost effective to deploy at scale and supporting improved and earlier detection,” CEO John Kelly said.

“We anticipate seeing this trend continue with a broader range of infectious disease testing being funded for deployment at home.”

AT1 last traded at 2.8cps.

AT1 by the numbers
More From The Market Online
The Market Online Video

ASX Daily Close: ASX matches futures prediction on a green Friday | 21 June 2024

The ASX200 reversed its trend to end the week in the green, up 0.35%. Nearly all…
The Market Online Video

ASX Market Update: Stocks swing from green with energy to remorseful red | 21 June, 2024

The ASX200 came out the gate in the green on Friday, but slipped well below the red line within the first hour of

Week 25 Wrap: No RBA cut yet; India stocks shake off Modi jitters; China concerns remain

The RBA keeps rates on pause; Guzman Gomez falls nearly -5% on Friday; Droneshield's new ATH;…

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

The one defining feature of our post-COVID 'new normal' is a USA swing towards domestic supply…